Literature DB >> 22710407

βig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis.

Zhen Li1, Zhifeng Miao, Guanghua Jin, Xiaoxia Li, Hongwu Li, Zhidong Lv, Hui-Mian Xu.   

Abstract

βig-h3 is an extracellular matrix protein and its expression is highly induced by transforming growth factor (TGF-β). It has also been suggested to play an important role in the growth and invasion of colon and pancreatic cancers. In the present study, we demonstrated that βig-h3 is expressed in mesothelial cells, especially in patients with advanced gastric cancer. The positive rate of βig-h3 was significantly higher in cases with a more invasive and advanced serous-type, with visible peritoneal metastasis, and in peritoneal lavage cytological examination (PLC) (+) and peritoneal lavage fluid CEA mRNA(+) subgroups (p<0.05). Our study also showed that the expression of βig-h3 gradually increased with increasing TGF-β1 concentrations in vitro in a time-dependant manner. In addition, βig-h3 also induced human gastric carcinoma cell line (SGC-7901) cell adhesion in a dose-dependent manner and significantly increased cell migration and proliferation. The results suggest that βig-h3 expression in peritoneal mesothelial cells in gastric cancer patients is a marker of the biological behavior of gastric cancer and plays an important role in the process of peritoneal carcinomatosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710407     DOI: 10.3892/mmr.2012.951

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis.

Authors:  Guo-Xiao Liu; Hong-Qing Xi; Xiao-Yan Sun; Bo Wei
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

2.  PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.

Authors:  Pei Wu; Jinou Wang; Xiaoyun Mao; Huimian Xu; Zhi Zhu
Journal:  Histol Histopathol       Date:  2021-01-14       Impact factor: 2.303

3.  BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells.

Authors:  Sofieke E Klamer; Carlijn G M Kuijk; Peter L Hordijk; C Ellen van der Schoot; Marieke von Lindern; Paula B van Hennik; Carlijn Voermans
Journal:  Cell Adh Migr       Date:  2013-10-08       Impact factor: 3.405

4.  Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.

Authors:  Bibo Tan; Yong Li; Qun Zhao; Liqiao Fan; Dong Wang; Yü Liu
Journal:  Tumour Biol       Date:  2013-09-27

5.  Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.

Authors:  Zhen Li; Dewei Zhang; Hao Zhang; Zhifeng Miao; Yuanxin Tang; Gongping Sun; Dongqiu Dai
Journal:  Tumour Biol       Date:  2013-11-27

6.  Mechanisms of peritoneal dissemination in gastric cancer.

Authors:  Feng Sun; Min Feng; Wenxian Guan
Journal:  Oncol Lett       Date:  2017-10-09       Impact factor: 2.967

7.  Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.

Authors:  Motohiko Tokuhisa; Yasushi Ichikawa; Nobuyoshi Kosaka; Takahiro Ochiya; Masakazu Yashiro; Kosei Hirakawa; Takashi Kosaka; Hirochika Makino; Hirotoshi Akiyama; Chikara Kunisaki; Itaru Endo
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

8.  β-inducible gene-h3 promotes human breast carcinoma cell metastasis by activating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway.

Authors:  Jiaxin Zhang; Zhaojiangbo Li
Journal:  Exp Ther Med       Date:  2018-01-23       Impact factor: 2.447

Review 9.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.